Philippines - English - FDA (Food And Drug Administration)

ferrous sulfate , folic acid - film-coated tablet - 300 mg (equivalent to 90 mg elemental iron)/ 250 mcg

Philippines - English - FDA (Food And Drug Administration)

st. raphael archangel pharmaceutical product distribution - ferrous sulfate , folic acid - film-coated tablet - 300 mg (equivalent to 90 mg elemental iron)/ 250 mcg

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - vitamin b-complex , lysine , iron - syrup - each 5ml contains; thiamine hydrochloride (vitamin b1) - 10mg pyridoxine hydrochloride (vitamin b6)-5mg cyanocobalamin (vitamin b12)-25mcg l-lysine hydrochloride-300mg iron(as ferric pyrophospate soluble) - 30mg (equivalent to 250mg ferric pyrophosphate soluble) - l-lysine hcl and ferric pyrophosphate (equivalent to elemental iron). it also includes b-complex vitamins such as b 1 , b 6 and b 12 . this product also contains alcohol 0.95% v/v subcomponent. - this product is indicated for the treatment and prevention of vitamin b complex deficiency and iron deficiency anemia (ida).

Philippines - English - FDA (Food And Drug Administration)

united laboratories, inc. - iron , folic acid , vitamin b -complex - tablet - each tablet contains: ferrous fumarate (elemental iron equivalent, 98.6 mg) 300 mg folic acid 500 mcg thiamine mononitrate (vitamin b1) 5 mg pyridoxine hydrochloride (vitamin b6) 5 mg cyanocobalamin (vitamin b12) 15 mcg

Philippines - English - FDA (Food And Drug Administration)

unilab, inc. - iron , pyridoxine (vitamin b6) , cyanocobalamin (vitamin b12) folic acid - tablet - each tablet contains: iron, elemental (as ferrous sulfate dried, 187 mg) - 60 mg folic acid - 600 mcg pyridoxine hcl (vit b6) - 20 mg cyanocobalamin (vit b12) - 25 mcg

United States - English - NLM (National Library of Medicine)

jaymac pharma - levomefolate magnesium (unii: 1vzz62r081) (levomefolic acid - unii:8s95dh25xc), leucovorin (unii: q573i9dvlp) (leucovorin - unii:q573i9dvlp), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous cysteine glycinate (unii: 8b4op7rk5n) (ferrous cation - unii:gw89581owr), magnesium ascorbate (unii: 0n1g678593) (ascorbic acid - unii:pq6ck8pd0r), zinc ascorbate (unii: 9ti35313xw) (ascorbic acid - unii:pq6ck8pd0r), cocarboxylase (unii: q57971654y) (cocarboxylase - unii:q57971654y), flavin a - levomefolic acid 5.23 mg - enbrace® hr is indicated in the treatment of vitamin deficiency - specifically vitamin b12 deficiency, and the prevention of vitamin b12 -cofactor deficiency, l-methylfolate. requirements of vitamin b9 and/or vitamin b12 in excess of normal due to pregnancy can usually be met with oral supplementation.

Philippines - English - FDA (Food And Drug Administration)

atc healthcare international corp. - multivitamins , iron - hard gelatin capsule - vitamin b1 2 mg, vitamin b2 2 mg, nicotinamide 20 mg, vitamin b6 2 mg, folic acid 400 mcg, vitamin b12 10 mcg, vitamin c 100 mg and elemental iron 65.73 mg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - iron as iron dextran - oral solution/suspension - iron as iron dextran mineral-iron active 100.0 mg/ml - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - iron deficiency | anaemia

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - iron dextran (unii: 95hr524n2m) (ferric cation - unii:91o4lml611) - intravenous or intramuscular injections of infed are indicated for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. hypersensitivity to the product. all anemias not associated with iron deficiency.

United States - English - NLM (National Library of Medicine)

amella pharma, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), zinc citrate (unii: k72i3dex9b) (zinc cation - unii:13s1s8sf37) - feonyx should not be used by patients with a known hypersensitivity to any of the listed ingredients. all iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias. precautions: general: take 2 hours after meals. do not exceed recommended dose. discontinue use if symptoms of intolerance appear. the type of anemia and the underlying cause or causes should be determined before starting therapy with feonyx tablets. ensure hgb, hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. folic acid: folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. f